Vimarsana
Biggest News Aggregation in the World

Page 28 - Global Head News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Global Head. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Global Head Today - Breaking & Trending Today

Insilico Medicine's leadership to address key challenges in AI drug discovery at BIO Convention - Vimarsana News

Insilico Medicine's leadership to address key challenges in AI drug discovery at BIO Convention

Leadership from clinical stage artificial intelligence (AI)-powered drug discovery company Insilico Medicine ("Insilico") will attend the BIO International Convention in San Diego June 3-6 and present on key issues facing AI drug discovery.

Charting The Course Of Hybrid Work | Gleb Tsipursky - Vimarsana News

Charting The Course Of Hybrid Work | Gleb Tsipursky

Hybrid work is transforming workplace culture by prioritizing employee well-being, flexibility, and inclusivity. Insights from leaders at Varian, The Hidden Genius Project, and Janus of Santa Cruz highlight its role in enhancing productivity and job satisfaction, while navigating challenges in maintaining culture and equity.

IFS ranked #1 for EAM market share in the 2024 Gartner[® ]Market Share: All Software Markets, Worldwide, 2023 report for third consecutive year - Vimarsana News

IFS ranked #1 for EAM market share in the 2024 Gartner[® ]Market Share: All Software Markets, Worldwide, 2023 report for third consecutive year

IFS ranked in the Gartner Market Share: All Software Markets, Worldwide, 2023 report London, UK, 22 May 2024 - IFS, the leading technology innovator in cloud and Industrial AI software, today...

OSE Immunotherapeutics : and Boehringer Ingelheim expand collaboration to develop first in class treatments for cancer and cardio renal metabolic diseases - Vimarsana News

OSE Immunotherapeutics : and Boehringer Ingelheim expand collaboration to develop first in class treatments for cancer and cardio renal metabolic diseases

OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseases Nantes,...

EFG Hermes acquires minority stake in Kenzi Wealth - Vimarsana News

EFG Hermes acquires minority stake in Kenzi Wealth

EFG Hermes acquires minority stake in Danish fintech Kenzi Wealth, signalling a new era in AI-powered investments for the MENA region.